These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 16507184

  • 1. The effect of nitric oxide on fentanyl and haloperidol-induced catalepsy in mice.
    Erkent U, Iskit AB, Onur R, Ilhan M.
    Eur J Anaesthesiol; 2006 Jul; 23(7):580-5. PubMed ID: 16507184
    [Abstract] [Full Text] [Related]

  • 2. Nitric oxide donors antagonize N-nitro-L-arginine and haloperidol catalepsy: potential implication for the treatment of Parkinsonism?
    Krzaścik P, Kostowski W.
    Pol J Pharmacol; 1997 Aug; 49(4):263-6. PubMed ID: 9437770
    [Abstract] [Full Text] [Related]

  • 3. L-NOARG, an inhibitor of nitric oxide synthase, induces catalepsy in mice.
    Marras RA, Martins AP, Del Bel EA, Guimarães FS.
    Neuroreport; 1995 Dec 29; 7(1):158-60. PubMed ID: 8742441
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Combined treatment of ascorbic acid or alpha-tocopherol with dopamine receptor antagonist or nitric oxide synthase inhibitor potentiates cataleptic effect in mice.
    Lazzarini M, Salum C, Del Bel EA.
    Psychopharmacology (Berl); 2005 Aug 29; 181(1):71-9. PubMed ID: 15806417
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Nitric oxide synthase inhibitors cause motor deficits in mice.
    Araki T, Mizutani H, Matsubara M, Imai Y, Mizugaki M, Itoyama Y.
    Eur Neuropsychopharmacol; 2001 Apr 29; 11(2):125-33. PubMed ID: 11313158
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Attenuation of morphine tolerance and dependence by aminoguanidine in mice.
    Abdel-Zaher AO, Hamdy MM, Aly SA, Abdel-Hady RH, Abdel-Rahman S.
    Eur J Pharmacol; 2006 Jul 01; 540(1-3):60-6. PubMed ID: 16730698
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Detrimental effects of nitric oxide inhibition on hepatic encephalopathy in rats with thioacetamide-induced fulminant hepatic failure: role of nitric oxide synthase isoforms.
    Chu CJ, Chang CC, Wang TF, Lee FY, Chang FY, Chen YC, Chan CC, Huang HC, Wang SS, Lee SD.
    J Gastroenterol Hepatol; 2006 Jul 01; 21(7):1194-9. PubMed ID: 16824075
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Involvement of L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of venlafaxine in mice.
    Dhir A, Kulkarni SK.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May 09; 31(4):921-5. PubMed ID: 17379375
    [Abstract] [Full Text] [Related]

  • 20. Role of nitric oxide in catalepsy and hyperthermia in morphine-dependent rats.
    Afify EA, Daabees TT, Gabra BH, Abou Zeit-Har MS.
    Pharmacol Res; 2001 Dec 09; 44(6):533-9. PubMed ID: 11735362
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.